{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-002459","form_type":"8-K","ticker":null,"cik":"0001750153","company_name":"Canoo Inc.","filed_at":"2025-01-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.711315+00:00","generated_at":"2026-05-27T11:19:55.120675+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Canoo receives Nasdaq delisting notice after Chapter 7 bankruptcy filing","bullets":["Company filed for Chapter 7 bankruptcy on January 17, 2025.","Nasdaq notified Canoo on January 22, 2025 of delisting due to bankruptcy and public interest concerns.","Canoo will not appeal; trading suspended at opening January 29, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-002459","json":"https://secwatch.observer/filing/0001628280-25-002459.json","markdown":"https://secwatch.observer/filing/0001628280-25-002459.md","text":"https://secwatch.observer/filing/0001628280-25-002459.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750153/000162828025002459/0001628280-25-002459-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750153/000162828025002459/goev-20250124.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T11:19:55.120675+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19d28c6ff5aa99696dd7f147086e7e553c667b76","claim":"Canoo Inc. received a nasdaq delisting notice notice regarding other.","evidence_excerpt":"January 22, 2025, the Company received a letter from the staff of the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that the Staff has determined that th","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1750153/000162828025002459/0001628280-25-002459-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001213900-26-059270","ticker":"XXI","company_name":"Twenty One Capital, Inc.","filed_at":"2026-05-20T12:49:08+00:00","headline":"Tether International acquires SoftBank's stake in Twenty One Capital; board members resign","event_type":"other_material","sec_items":["1.02","3.01","5.02","8.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-059270","json":"https://secwatch.observer/filing/0001213900-26-059270.json","markdown":"https://secwatch.observer/filing/0001213900-26-059270.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2070457/000121390026059270/0001213900-26-059270-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2070457/000121390026059270/ea0291071-8k_twenty.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 22, 2025, the Company received a letter from the staff of the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that the Staff has determined that th","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750153/000162828025002459/0001628280-25-002459-index.htm","comparable_excerpt":"o independent directors, the minimum number required during the transition period\nfor compliance with Section 303A.07(a) of the NYSE Listed Company Manual, as provided in Section 303A.00 of the NYSE Listed Company Manual","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2070457/000121390026059270/0001213900-26-059270-index.htm"}},{"accession":"0001493152-26-024495","ticker":"SOPA","company_name":"SOCIETY PASS INCORPORATED.","filed_at":"2026-05-20T10:05:33+00:00","headline":"Society Pass receives Nasdaq delisting notice after filing Chapter 11 bankruptcy","event_type":"other_material","sec_items":["3.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-024495","json":"https://secwatch.observer/filing/0001493152-26-024495.json","markdown":"https://secwatch.observer/filing/0001493152-26-024495.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817511/000149315226024495/0001493152-26-024495-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817511/000149315226024495/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 22, 2025, the Company received a letter from the staff of the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that the Staff has determined that th","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750153/000162828025002459/0001628280-25-002459-index.htm","comparable_excerpt":"May 14, 2026, the Company was notified by the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)\nthat Nasdaq had determined to delist the Company’s common stock, par value $0.0001 per share (the","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1817511/000149315226024495/0001493152-26-024495-index.htm"}},{"accession":"0001193125-26-230708","ticker":"BTM","company_name":"Bitcoin Depot Inc.","filed_at":"2026-05-19T20:01:24+00:00","headline":"Bitcoin Depot files Chapter 11; Nasdaq to suspend BTM stock and warrants on May 26","event_type":"other_material","sec_items":["3.01"],"materiality_score":0.95,"calibrated_materiality_score":0.95,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-230708","json":"https://secwatch.observer/filing/0001193125-26-230708.json","markdown":"https://secwatch.observer/filing/0001193125-26-230708.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1901799/000119312526230708/0001193125-26-230708-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1901799/000119312526230708/d228011d8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 22, 2025, the Company received a letter from the staff of the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that the Staff has determined that th","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750153/000162828025002459/0001628280-25-002459-index.htm","comparable_excerpt":"May 18, 2026, the Company received a letter from the Listing Qualifications Department staff of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the Debtors’ commencement of the Chapter 1","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1901799/000119312526230708/0001193125-26-230708-index.htm"}},{"accession":"0001437749-26-016538","ticker":"RVPH","company_name":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","filed_at":"2026-05-13T12:03:45+00:00","headline":"Reviva Pharmaceuticals to be delisted from Nasdaq May 14, 2026; will trade on OTCQB","event_type":"other_material","sec_items":["3.01","8.01"],"materiality_score":1.0,"calibrated_materiality_score":1.0,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-016538","json":"https://secwatch.observer/filing/0001437749-26-016538.json","markdown":"https://secwatch.observer/filing/0001437749-26-016538.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1742927/000143774926016538/0001437749-26-016538-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1742927/000143774926016538/rvph20260512_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 22, 2025, the Company received a letter from the staff of the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that the Staff has determined that th","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750153/000162828025002459/0001628280-25-002459-index.htm","comparable_excerpt":"May 12, 2026 indicating that the Panel had determined to delist the Company’s common stock from Nasdaq. The Company’s common stock will be suspended from trading on Nasdaq as of the open of trading on May 14, 2026. Begin","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1742927/000143774926016538/0001437749-26-016538-index.htm"}},{"accession":"0001437749-26-016455","ticker":"BKYI","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2026-05-12T20:46:03+00:00","headline":"BIO-key receives Nasdaq delisting notice; stock to move to OTC Markets on May 13","event_type":"other_material","sec_items":["3.01","7.01","9.01"],"materiality_score":0.95,"calibrated_materiality_score":0.95,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-016455","json":"https://secwatch.observer/filing/0001437749-26-016455.json","markdown":"https://secwatch.observer/filing/0001437749-26-016455.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926016455/0001437749-26-016455-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926016455/bkyi20260512_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 22, 2025, the Company received a letter from the staff of the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that the Staff has determined that th","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750153/000162828025002459/0001628280-25-002459-index.htm","comparable_excerpt":"May 6, 2026, BIO-key International, Inc. (the “ Company ”) received notice from the staff of The Nasdaq Stock Market, LLC (“ Nasdaq ”) stating that the Company had not regained compliance with Nasdaq Listing Rule 5550(a)","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926016455/0001437749-26-016455-index.htm"}},{"accession":"0001493152-26-026529","ticker":"HCWB","company_name":"HCW Biologics Inc.","filed_at":"2026-06-01T11:30:18+00:00","headline":"Nasdaq panel grants HCW Biologics extension to July 29, 2026 to regain $1 bid price compliance","event_type":"other_material","sec_items":["3.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026529","json":"https://secwatch.observer/filing/0001493152-26-026529.json","markdown":"https://secwatch.observer/filing/0001493152-26-026529.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000149315226026529/0001493152-26-026529-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000149315226026529/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 22, 2025, the Company received a letter from the staff of the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that the Staff has determined that th","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750153/000162828025002459/0001628280-25-002459-index.htm","comparable_excerpt":"ng the exception period that may\naffect the Company’s compliance with Nasdaq requirements. If the Company regains compliance and satisfies the terms of the exception,\nthe Panel intends to impose a Discretionary Panel Monitor on the Company for an additional one-year period, pursuant to Listing Rule\n5815(d)(4)(A). SIGNATURES Pursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized. HCW BIOLOGICS INC. Date: June 1, 2026 By: /s/\n Hing C. Wong Hing C. Wong, Founder and Chie","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1828673/000149315226026529/0001493152-26-026529-index.htm"}},{"accession":"0001213900-26-062844","ticker":"ADTX","company_name":"Aditxt, Inc.","filed_at":"2026-05-29T20:21:24+00:00","headline":"Aditxt receives Nasdaq deficiency for negative equity; delisting hearing set for June 11","event_type":"other_material","sec_items":["3.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062844","json":"https://secwatch.observer/filing/0001213900-26-062844.json","markdown":"https://secwatch.observer/filing/0001213900-26-062844.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026062844/0001213900-26-062844-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026062844/ea0292786-8k_aditxt.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 22, 2025, the Company received a letter from the staff of the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that the Staff has determined that th","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750153/000162828025002459/0001628280-25-002459-index.htm","comparable_excerpt":"May 27, 2026, Aditxt, Inc. (the “Company”)\nreceived a letter (the “Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market\nLLC (“Nasdaq”) notifying the Company that, based on the stockholders’ equity of $(35,174,386) reported in the Company’s\nQuarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company no longer satisfies the minimum\nstockholders’ equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1)\n(the “Stockholders’ Equity Requirement”). The Letter further","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026062844/0001213900-26-062844-index.htm"}},{"accession":"0001104659-26-066974","ticker":"LIMN","company_name":"Liminatus Pharma, Inc.","filed_at":"2026-05-27T20:30:41+00:00","headline":"Liminatus Pharma receives Nasdaq delisting notice; appeals filed","event_type":"other_material","sec_items":["3.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-066974","json":"https://secwatch.observer/filing/0001104659-26-066974.json","markdown":"https://secwatch.observer/filing/0001104659-26-066974.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926066974/0001104659-26-066974-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926066974/tm2615785d1_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 22, 2025, the Company received a letter from the staff of the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that the Staff has determined that th","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750153/000162828025002459/0001628280-25-002459-index.htm","comparable_excerpt":"May 20, 2026, the Company received a notice\nfrom Nasdaq stating that the Company had not regained compliance with the MVLS Rule and the MVPHS Rule. Accordingly, its securities will\nbe delisted from The Nasdaq Global Mark","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926066974/0001104659-26-066974-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}